Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    In the version history, 2026-02-12 adds Contacts/Locations and Study Status, and 2026-01-26 adds the entry 54; a deletion occurred on 2025-09-16.
    Difference
    0.3%
    Check dated 2026-02-18T06:50:21.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new version entry 'Revision: v3.4.2' was added to the version history, and notices including a government funding lapse message and 'Revision: v3.4.1' were removed. These changes are administrative and do not alter core page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:49:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operating status was added, and the revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:29:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page now includes a glossary, green highlights for additions, red highlights for deletions, and explicit revision labels (e.g., v3.4.0). These updates affect presentation only and do not change the study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-01-28T00:24:14.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the Record History and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T01:18:39.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer updates include changing the revision label from v3.3.2 to v3.3.3 and removing the HHS Vulnerability Disclosure link. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T20:56:07.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.